Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia
Clinical trial NCT01623167 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01623167
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-02
- Primary completion
- 2018-01-30
- Enrollment
- 207
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.